Jack Spicer is Lecturer in Criminology at UWE, Bristol, UK. His research interests include the functioning of illicit drug markets, drug law enforcement and drug policy. In 2019 he was awarded “Best Early Career Researcher” by the International Society for the Study of Drug Policy.

“Bringing a wealth of detail and clarity to the study of this topic, Spicer invites the reader … . Spicer cultivates a rich insight into his own experiences of the ethnographic process, valuable to both those embarking on early experiences of fieldwork and those seeking to contextualize the book’s substantive insights. … Overall, the book makes a valuable contribution to the literature on county lines and policing. Spicer invites us to examine … with a pragmatic, critical eye.” (Hannah Marshall, The British Journal of Criminology, Vol. 62 (2), 2022)

• 1. Introduction.- 2. County Lines.- 3. Policing Drug Markets.- 4. Navigating A ‘Newsy’ Field.- 5. Policing A Crisis?.- 6. New Tactics.- 7. More Of The Same?.- 8. Drug Market Priorities.- 9. Conclusion.

Jack Spicer is Lecturer in Criminology at UWE, Bristol, UK. His research interests include the functioning of illicit drug markets, drug law enforcement and drug policy. In 2019 he was awarded “Best Early Career Researcher” by the International Society for the Study of Drug Policy.

“Bringing a wealth of detail and clarity to the study of this topic, Spicer invites the reader … . Spicer cultivates a rich insight into his own experiences of the ethnographic process, valuable to both those embarking on early experiences of fieldwork and those seeking to contextualize the book’s substantive insights. … Overall, the book makes a valuable contribution to the literature on county lines and policing. Spicer invites us to examine … with a pragmatic, critical eye.” (Hannah Marshall, The British Journal of Criminology, Vol. 62 (2), 2022)

• 1. Introduction.- 2. County Lines.- 3. Policing Drug Markets.- 4. Navigating A ‘Newsy’ Field.- 5. Policing A Crisis?.- 6. New Tactics.- 7. More Of The Same?.- 8. Drug Market Priorities.- 9. Conclusion.